Home/Filings/4/0001051339-21-000002
4//SEC Filing

BENARROCH GEORGES 4

Accession 0001051339-21-000002

CIK 0001164888other

Filed

Apr 13, 8:00 PM ET

Accepted

Apr 14, 11:49 AM ET

Size

8.2 KB

Accession

0001051339-21-000002

Insider Transaction Report

Form 4
Period: 2021-03-16
BENARROCH GEORGES
DirectorPresident
Transactions
  • Exercise/Conversion

    Non-qualified Stock Option (Right to Buy)

    2021-03-16$0.03/sh181,250$5,98118,750 total
    Exercise: $0.03From: 2021-03-16Exp: 2021-12-16Common Shares (181,250 underlying)
  • Exercise/Conversion

    Common Shares

    2021-03-16$0.03/sh+181,250$5,981181,250 total
Footnotes (2)
  • [F1]George Benarroch exercised 181,250 options to purchase 181,250 common shares at $0.033 per share.
  • [F2]Company confirmed option exercise with share issuance to be completed when company reorganization and name changed completed

Issuer

Kyto Technology & Life Science, Inc.

CIK 0001164888

Entity typeother

Related Parties

1
  • filerCIK 0001051339

Filing Metadata

Form type
4
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 11:49 AM ET
Size
8.2 KB